Latigo Biotherapeutics

Latigo Biotherapeutics is a clinical-stage biotechnology company dedicated to developing non-opioid analgesic drugs that target the fundamental mechanisms of pain transmission. The company's proprietary in-house technology leverages state-of-the-art artificial intelligence, machine learning, structure-based and knowledge-based design techniques to develop novel drugs targeting human genetics-validated targets, optimizing potency and selectivity.